The results showed that the main active ingredients of the Asarum–Angelica drug pair had a strong binding ability with BCL2, suggesting that the drug pair may promote inflammatory cell apoptosis and alleviate periodontitis inflammation by interfering with the formation of BCL2. This evidence concerns the gene BCL2 and periodontitis.